CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Dronedarone hydrochloride

Last Updated: September 18, 2009
Result type: Reports
Project Number: S0177
Product Line: Reimbursement Review

Generic Name: Dronedarone hydrochloride

Brand Name: Multaq

Manufacturer: Sanofi-Aventis Canada Inc.

Indications: Atrial fibrillation

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 27, 2010

Recommendation Type: Do not list